DEXMEDETOMIDINE HYDROCHLORIDE
DEXMEDETOMIDINE HYDROCHLORIDE
Approval overview DEXMEDETOMIDINE HYDROCHLORIDE is listed in Drugs@FDA under application 206628 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient DEXMEDETOMIDINE HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML) Sponsor HQ SPCLT PHARMA Submission history Latest submission status date: 2024-03-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview DEXMEDETOMIDINE HYDROCHLORIDE is listed in Drugs@FDA under application 206628 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DEXMEDETOMIDINE HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML) Sponsor HQ SPCLT PHARMA Submission history Latest submission status date: 2024-03-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.